|
44
|
273
|
2rr11 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
7
|
97
|
2r29A |
Neutralization of dengue virus by a serotype cross-reactive antibody elucidated by cryoelectron microscopy and x-ray crystallography |
|
38
|
236
|
2r063 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
38
|
236
|
2r073 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2r072 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2r064 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
41
|
273
|
2r071 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
42
|
273
|
2r061 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2r062 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
38
|
236
|
2r043 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2r044 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
6
|
97
|
2r69A |
Crystal structure of fab 1a1d-2 complexed with e-diii of dengue virus at 3.8 angstrom resolution |
|
41
|
273
|
2r041 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2r074 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2r042 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
1
|
16
|
2qv1C |
Crystal structure of hcv ns3-4a v36m mutant |
|
108
|
431
|
2qeqA |
Crystal structure of kunjin virus ns3 helicase |
|
82
|
262
|
2px2A |
Crystal structure of the murray valley encephalitis virus ns5 2'-o methyltransferase domain in complex with sah (monoclinic form 1) |
|
84
|
262
|
2pxaA |
Crystal structure of the murray valley encephalitis virus ns5 2'-o methyltransferase domain in complex with sah and gtpg |
|
89
|
263
|
2pxcA |
Crystal structure of the murray valley encephalitis virus ns5 2'-o methyltransferase domain in complex with sam and gtpa |
|
85
|
263
|
2px4A |
Crystal structure of the murray valley encephalitis virus ns5 2'-o methyltransferase domain in complex with sah (monoclinic form 2) |
|
87
|
264
|
2px8A |
Crystal structure of the murray valley encephalitis virus ns5 2'-o methyltransferase domain in complex with sah and 7m-gtp |
|
41
|
300
|
2plv1 |
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus |
|
61
|
268
|
2plv2 |
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus |
|
91
|
265
|
2px5A |
Crystal structure of the murray valley encephalitis virus ns5 2'-o methyltransferase domain in complex with sah (orthorhombic crystal form) |
|
12
|
101
|
2p5pA |
Crystal structure analysis of the west nile virus envelope (e) protein domain iii |
|
0
|
16
|
2p59C |
Crystal structure of hepatitis c virus ns3.4a protease |
|
38
|
235
|
2plv3 |
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus |
|
3
|
68
|
2plv4 |
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus |
|
41
|
181
|
2oc7A |
Structure of hepatitis c viral ns3 protease domain complexed with ns4a peptide and ketoamide sch571696 |
|
42
|
183
|
2oc8A |
Structure of hepatitis c viral ns3 protease domain complexed with ns4a peptide and ketoamide sch503034 |
|
39
|
180
|
2obqA |
Discovery of the hcv ns3/4a protease inhibitor sch503034. key steps in structure-based optimization |
|
83
|
262
|
2oy0A |
Crystal structure of the west nile virus methyltransferase |
|
46
|
183
|
2oc1A |
Structure of the hcv ns3/4a protease inhibitor cvs4819 |
|
34
|
151
|
2oinA |
Crystal structure of hcv ns3-4a r155k muntant |
|
0
|
22
|
2oc1B |
Structure of the hcv ns3/4a protease inhibitor cvs4819 |
|
89
|
259
|
2p1dA |
Crystal structure of dengue methyltransferase in complex with gtp and s-adenosyl-l-homocysteine |
|
0
|
23
|
2o8mC |
Crystal structure of the s139a mutant of hepatitis c virus ns3/4a protease |
|
1
|
16
|
2oinC |
Crystal structure of hcv ns3-4a r155k muntant |
|
0
|
22
|
2oc7B |
Structure of hepatitis c viral ns3 protease domain complexed with ns4a peptide and ketoamide sch571696 |
|
0
|
22
|
2oc0B |
Structure of ns3 complexed with a ketoamide inhibitor sch491762 |
|
44
|
185
|
2o8mA |
Crystal structure of the s139a mutant of hepatitis c virus ns3/4a protease |
|
202
|
564
|
2o5dA |
Thiazolone-acylsulfonamides as novel hcv ns5b polymerase allosteric inhibitors: convergence of structure-based drug design and x-ray crystallographic study |
|
0
|
22
|
2oc8B |
Structure of hepatitis c viral ns3 protease domain complexed with ns4a peptide and ketoamide sch503034 |
|
40
|
181
|
2oc0A |
Structure of ns3 complexed with a ketoamide inhibitor sch491762 |
|
12
|
63
|
2mtsA |
Three-dimensional structure and interaction studies of hepatitis c virus p7 in 1,2-dihexanoyl-sn-glycero-3-phosphocholine by solution nuclear magnetic resonance |
|
20
|
67
|
2m4hA |
Solution structure of the core domain (10-76) of the feline calicivirus vpg protein |
|
5
|
27
|
2lifA |
Solution structure of kkgf |
|
38
|
240
|
2m9qA |
Nmr structure of an inhibitor bound dengue ns3 protease |
|
7
|
31
|
2lzpA |
Structure of ns2(2-32) gbvb protein |
